Showing results (91-100 of 204) with videos related to

Sort By:
Pageof 21
The European Respiratory Journal|February 27, 2016
Lung microbiome dynamics in COPD exacerbationsZhang Wang, Mona Bafadhel, Koirobi Haldar, et al.
American Journal of Respiratory and Critical Care Medicine|May 26, 2023
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological TrialsMario Cazzola, Paola Rogliani, Peter J Barnes, et al.
Chest|August 22, 2024
The Responsiveness of Exercise Tests in COPD: A Randomized Controlled TrialTheresa C Harvey-Dunstan, Molly M Baldwin, Ruth Tal-Singer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 30, 2021
Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN StudyToshihiko Kaise, Eishin Sakihara, Kentaro Tamaki, et al.
ERJ Open Research|December 10, 2024
Evaluation of intranasal TLR2/6 agonist INNA-051: safety, tolerability and proof of pharmacologyFrancesca A Mercuri, Scott White, Hayley A McQuilten, et al.
American Journal of Respiratory and Critical Care Medicine|January 9, 2016
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification ConsortiumBruce E Miller, Ruth Tal-Singer, Stephen I Rennard, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 25, 2021
Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) StudyKentaro Tamaki, Eishin Sakihara, Hiroaki Miyata, et al.
BMJ Open Respiratory Research|June 25, 2026
GOLD 2026 COPD ABE assessment tool to identify individuals at high risk in a UK multicentre COPD cohort (ERICA)Gbenga Adesoye, Alastair Watson, Tengyu Zhao, et al.
ERJ Open Research|March 25, 2025
Dysregulation of lipid mediators in patients with frequent exacerbations of COPDMarie Fisk, Esteban A Gomez, Yuan Sun, et al.
ERJ Open Research|October 29, 2025
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged populationFrancesca A Mercuri, Aowen Zhuang, Hayley A McQuilten, et al.
Pageof 21